BlackRock
LKFT

BlackRock’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BlackRock’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
338,152
+26,046
+8% +$739K ﹤0.01% 3674
2026
Q1 		$9.36M Sell
312,106
-2,163
-0.7% -$71.6K ﹤0.01% 3557
2025
Q4 		$10.3M Buy
314,269
+74,426
+31% +$2.4M ﹤0.01% 3456
2025
Q3 		$8.31M Buy
239,843
+13,787
+6% +$441K ﹤0.01% 3547
2025
Q2 		$6.33M Sell
226,056
-27,895
-11% -$748K ﹤0.01% 3657
2025
Q1 		$6.38M Sell
253,951
-170,713
-40% -$4.31M ﹤0.01% 3537
2024
Q4 		$11.7M Sell
424,664
-79,602
-16% -$2.22M ﹤0.01% 3349
2024
Q3 		$14.5M Sell
504,266
-56,092
-10% -$1.53M ﹤0.01% 3218
2024
Q2 		$13.9M Buy
560,358
+41,067
+8% +$1.17M ﹤0.01% 3191
2024
Q1 		$16.7M Buy
519,291
+56,031
+12% +$2.08M ﹤0.01% 3084
2023
Q4 		$18.8M Buy
463,260
+22,655
+5% +$834K ﹤0.01% 3045
2023
Q3 		$15.2M Sell
440,605
-41,258
-9% -$1.61M ﹤0.01% 3095
2023
Q2 		$19.6M Buy
481,863
+2,490
+0.5% +$102K ﹤0.01% 3050
2023
Q1 		$18.5M Sell
479,373
-15,189
-3% -$624K ﹤0.01% 3018
2022
Q4 		$21.9M Buy
494,562
+12,838
+3% +$540K ﹤0.01% 2983
2022
Q3 		$20.5M Sell
481,724
-34,309
-7% -$1.76M ﹤0.01% 3015
2022
Q2 		$28.8M Sell
516,033
-1,578
-0.3% -$93.6K ﹤0.01% 2876
2022
Q1 		$32.1M Buy
517,611
+164,912
+47% +$10.1M ﹤0.01% 2867
2021
Q4 		$19.4M Sell
352,699
-37,060
-10% -$1.93M ﹤0.01% 3292
2021
Q3 		$20.5M Sell
389,759
-17,416
-4% -$1.03M ﹤0.01% 3256
2021
Q2 		$28.1M Buy
407,175
+346,013
+566% +$26.4M ﹤0.01% 3091
2021
Q1 		$4.71M Sell
61,162
-247,628
-80% -$22.8M ﹤0.01% 3967
2020
Q4 		$30.6M Sell
308,790
-34,694
-10% -$4.24M ﹤0.01% 2780
2020
Q3 		$48.7M Sell
343,484
-634
-0.2% -$106K ﹤0.01% 2320
2020
Q2 		$67.9M Buy
344,118
+26,470
+8% +$5.48M ﹤0.01% 2080
2020
Q1 		$62.2M Buy
317,648
+32,416
+11% +$6.97M ﹤0.01% 1933
2019
Q4 		$59M Sell
285,232
-1,191
-0.4% -$220K ﹤0.01% 2255
2019
Q3 		$43.7M Sell
286,423
-1,166
-0.4% -$191K ﹤0.01% 2381
2019
Q2 		$37.1M Sell
287,589
-3,966
-1% -$471K ﹤0.01% 2499
2019
Q1 		$34.3M Sell
291,555
-24,768
-8% -$2.5M ﹤0.01% 2492
2018
Q4 		$29M Sell
316,323
-49,090
-13% -$4.98M ﹤0.01% 2527
2018
Q3 		$41.1M Buy
365,413
+56,848
+18% +$6.01M ﹤0.01% 2489
2018
Q2 		$28.4M Sell
308,565
-16,255
-5% -$1.58M ﹤0.01% 2666
2018
Q1 		$32.4M Sell
324,820
-21,982
-6% -$2.37M ﹤0.01% 2509
2017
Q4 		$32.5M Buy
346,802
+196,202
+130% +$18.6M ﹤0.01% 2518
2017
Q3 		$15.3M Buy
150,600
+2,300
+2% +$201K ﹤0.01% 2937
2017
Q2 		$11.3M Sell
148,300
-1,200
-0.8% -$101K ﹤0.01% 3098
2017
Q1 		$12.9M Buy
+149,500
New +$10.8M ﹤0.01% 2994
2016
Q3 		– Sell
-300
Closed -$17K – 3714
2016
Q2 		$17K Buy
+300
New +$15.1K ﹤0.01% 3305
2016
Q1 		– Sell
-500
Closed -$31K – 3683
2015
Q4 		$31K Buy
+500
New +$25.6K ﹤0.01% 2345
2015
Q3 		– Sell
-9,600
Closed -$494K – 3226
2015
Q2 		$494K Buy
+9,600
New +$509K ﹤0.01% 1541

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

BlackRock's LKFT Position: Q2 2026 in Review

BlackRock increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 8.3% in Q2 2026, buying an estimated $739K and bringing the position to 338,152 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3674.

BlackRock first reported a position in LKFT in Q2 2015 and has held it in 41 quarters since. The position peaked at $67.9M in Q2 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • BlackRock held 338,152 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.1M as of Q2 2026.
  • BlackRock bought 26,046 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $739K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3674 holding.
  • BlackRock first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 41 quarters since.
  • BlackRock's Lakefront Biotherapeutics American Depositary Shares position peaked at $67.9M in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.